SLC6A3 and Anxiety: The association between decreased amygdala-striatal DAT availability and better anxiolytic effects is congruent with our recent PET study in which baseline DAT BPND correlated positively with anxiety severity, indicative of dopamine hypoactivity in SAD [23].